Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply Drs Kloos and Barth,1 employees and equity owners of Veracyte raise questions about the design and findings of our study examining the effect of Veracyte’s Afirma gene expression classifier (GEC) on the practice of 10 thyroid surgeons at an academic institution.2
Noureldine SI, Zeiger MA, Tufano RP. Gene Expression Classifier Testing and the Surgical Decision-Making Process for Patients With Thyroid Nodules—Reply. JAMA Otolaryngol Head Neck Surg. 2016;142(8):807. doi:10.1001/jamaoto.2016.0515
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: